CDHA CAAR

“Lifespan Respite Care Program: State Program Enhancement Grants – Reposting Opportunity to Apply,” (HHS-2021-ACL-AOA-LRLI-0115, application deadline Aug. 23, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=334854

“Limited Competition: Data Management and Coordinating Center (DMCC) and a Collaborative Research Space for Translational Research on Exceptional Longevity (U24 Clinical Trial Not Allowed),” (RFA-AG-22-023, National Institute on Aging, application deadline October 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-023.html

A. “Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed),” (RFA-AG-22-015, National Institute on Aging, application deadline October 20, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-015.html

B. “Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed),” (RFA-AG-22-021, National Institute on Aging, application deadline November 2, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-021.html

C. “Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimer’s Disease and Related Dementias (R61/R33 Clinical Trial Required),” (RFA-AG-22-024, National Institute on Aging, application deadline October 20, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-024.html

D. “Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required),” (RFA-HL-22-014, a reissue of RFA-HL-21-003, National Institute on Aging, in conjunction with other agencies, application deadline October 20, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-HL-22-014.html

E. “BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional),” (RFA-MH-21-205, a reissue of RFA-MH-19-400, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 13, 2021, Oct. 11, 2022, and Oct. 11, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-205.html

“Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed),” (PAR-21-281, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, 2022 and Feb. 5, 2023). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic Experimental Studies with Humans),” (PAR-21-280).

grants.nih.gov/grants/guide/pa-files/PAR-21-281.html

A. “PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed),” (PA-21-259, a reissue of PA-20-260, National Institute on Aging, in conjunction with other agencies, application deadline Sept. 5, Jan. 5, and April 5). Note: There are three companion funding announcements (follow the link under “Companion Funding Opportunity”): “PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required),” (PA-21-260); “PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required),” (PA-21-261); and “PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed),” (PA-21-262).

grants.nih.gov/grants/guide/pa-files/PA-21-259.html

B. “Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic Experimental Studies with Humans),” (PAR-21-280, National Institute on Aging, deadline for application March 5, 2022, March 5, 2021). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed),” (PAR-21-281).

grants.nih.gov/grants/guide/pa-files/PAR-21-280.html

C. “Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed),” (RFA-AG-22-022, National Institute on Aging, Letter of Intent due date September 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-022.html

D. “Grants for Early Medical/Surgical Specialists’ Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional),” (RFA-AG-22-027, National Institute on Aging, Letter of Intent Due Data October 2, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-027.html

A. “Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed),” (RFA-AG-22-025, National Institute on Aging, application deadline October 20, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-025.html

B. “The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional),” (PAR-21-275, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-21-275.html

A. “Role of Adaptive Immunity in Etiology of Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Optional),” (RFA-AG-22-017, National Institute on Aging, application deadline Oct. 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-017.html

B. “Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed),” (RFA-AG-22-018, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-018.html

A. “NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed),” (RFA-AG-22-003, National Institute on Aging, application deadline October 4, 2021). Note: There are three companion funding announcements (follow the link under “Companion Funding Opportunity”): “NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed),” (RFA-AG-22-004); “NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional),” (RFA-AG-22-007); and, “NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional),” (RFA-AG-22-014).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-003.html

B. “High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimer’s Disease (R01 Clinical Trial Not Allowed),” (RFA-AG-22-019, National Institute on Aging, application deadline October 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-019.html

C. “BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed),” (RFA-NS-21-026, a reissue of RFA-NS-18-020, National Institute on Aging, in conjunction with other agencies, application deadlines Oct. 29, 2021, May 2, 2022, Oct. 28, 2022, May 1, 2023, and Oct. 27, 2023). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed),” (RFA-NS-21-027).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-026.html

D. “HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed),” (RFA-NS-21-029, reissue of RFA-NS-21-016, National Institute on Aging, in conjunction with other agencies, application deadline July 19, 2021, Oct. 13, 2021, June 9, 2022, Oct. 11, 2022, June 9, 2023, and Oct. 10, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-029.html

A. “National Technical Assistance Center on Kinship and Grandfamilies,” (HHS-2021-ACL-AOA-TAKG-0103, deadline for applications July 26, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=333517

B. “Alzheimer’s Disease Programs Initiative – Grants to States and Communities (Round Two),” (HHS-2021-ACL-AOA-ADPI-0086, deadline for applications August 2, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=331701

“NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed),” (PAR-21-217, National Institute on Aging, first application deadline August 8, 2021). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31),” (PAR-21-218); and, “NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed),” (PAR-21-220).

grants.nih.gov/grants/guide/pa-files/PAR-21-217.html

“Alzheimer’s Disease Programs Initiative – Dementia Capability in Indian Country,” (HHS-2021-ACL-AOA-ADPI-0104, application deadline July 19, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=333594

“Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required),” (PAR-21-154, a reissue of PAR-19-133, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 25, June 25, and Oct. 25). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed),” (PAR-21-155).

grants.nih.gov/grants/guide/pa-files/PAR-21-154.html

“BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed),” (RFA-MH-21-175, a reissue of RFA-MH-19-136, National Institute on Aging, in conjunction with other agencies, application deadline October 08, 2021, October 07, 2022, and October 08, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-175.html

“Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional),” (PAR-21-233, a reissue of PAR-21-162, National Institute on Aging, in conjunction with other agencies, application deadlines August 10, 2021, February 9, 2022, August 9, 2022, February 9, 2023, August 9, 2023, February 9, 2024).

grants.nih.gov/grants/guide/pa-files/PAR-21-233.html

“National Adult Protective Services Training Center,” (HHS-2021-ACL-AOA-EJRC-0101, application deadline May 29, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=332662

A. “Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed),” (PAR-21-213, National Institute on Aging, in conjunction with other agencies, letter of intent due dates May 9, 2021; October 8, 2021).

grants.nih.gov/grants/guide/pa-files/PAR-21-213.html

B. “Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimer’s Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional),” (PAR-21-207, National Institute on Aging, letter of intent deadline September 15, 2021, January 26, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-21-207.html

“Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional),” (PAR-21-162, National Institute on Aging, in conjunction with other agencies, application deadlines August 10, 2021, February 9, 2022, August 9, 2022, February 9, 2023, August 9, 2023, February 9, 2024). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional),” (PAR-21-163).

grants.nih.gov/grants/guide/pa-files/PAR-21-162.html

A. “Innovations in Nutrition Programs and Services – Statewide Research,” (HHS-2021-ACL-AOA-INNU-0092, application deadline May 24, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=332358

B. “Innovations in Nutrition Programs and Services – Community Research,” (HHS-2021-ACL-AOA-INNU-0084, application deadline May 24, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=332357

A. “Limited Competition: Alzheimer’s Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed),” (PAR-21-212, National Institute on Aging, application deadline Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-21-212.html

B. “Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer’s Disease and Related Dementias (R25 – Clinical Trial Not Allowed),” (RFA-AG-22-010, National Institute on Aging, application deadline October 4, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-010.html

C. “Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional),” (RFA-MD-21-004, National Institute on Aging, in conjunction with other agencies, application deadline August 24, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-MD-21-004.html

D. “Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional),” (RFA-TW-21-001, a reissue of RFA-TW-14-001, National Institute on Aging, in conjunction with other agencies, application deadline July 8, 2021). Note: here is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) – Research Training (Collaborative U2R Clinical Trial Optional),” (RFA-TW-21-002).

grants.nih.gov/grants/guide/rfa-files/RFA-TW-21-001.html

A. “Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed),” (PAR-21-169, National Institute on Aging, in conjunction with other agencies, application deadlines May 26, 2021, May 26, 2022, and May 26, 2023). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 – Clinical Trial Not Allowed),” (PAR-21-173).

grants.nih.gov/grants/guide/pa-files/PAR-21-169.html

B. “High-Priority Behavioral and Social Research Networks in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R24 Clinical Trial Optional),” (RFA-AG-22-012, reissue of RFA-AG-19-016, National Institute on Aging, application deadline June 23, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-012.html

C. “High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional),” (RFA-AG-22-013, a reissue of RFA-AG-19-015, National Institute on Aging, application deadline June 23, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-013.html

“Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) Activity Code,” (PAR-21-163, National Institute on Aging). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Small Business Innovation Research (SBIR) Cooperative Agreements – Fast-Track,” (PAR-20-111); and, “Phase 1 Exploratory/Developmental Cooperative Agreement/Exploratory/Developmental Cooperative Agreement Phase II,” (PAR-20-122).

grants.nih.gov/grants/guide/pa-files/PAR-21-163.html

“AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed),” (PAR-21-141, National Institute on Aging, application deadlines May 25, 2021; May 25, 2022; May 25, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-21-141.html

“The Midlife in the United States Study (U19 Clinical Trial Not Allowed),” (PAR-21-156, National Institute on Aging, application deadlines April 26, 2021 and November 18, 2021). Note:  There is a companion funding announcement (follow the link under “Companion Funding Opportunity” ): “The Midlife in the United States Study – Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed),” (PAR-21-157).

grants.nih.gov/grants/guide/pa-files/PAR-21-156.html

“Alzheimer’s Disease Programs Initiative – Grants to States and Communities,” (HHS-2021-ACL-AOA-ADPI-0083, application deadline April 26, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=330640

“NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed),” (PA-21-151, a reissue of PA-20-207, National Institute on Aging, in conjunction with other agencies). Note: List of application deadlines available at the site.

grants.nih.gov/grants/guide/pa-files/PA-21-151.html

A. “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required),” (PAR-21-144, a reissues of of PAR-19-384, US National Institute on Aging).

grants.nih.gov/grants/guide/pa-files/PAR-21-144.html

B. “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed),” (PAR-21-145, a reissue of PAR-19-373, National Institute on Aging, ).

grants.nih.gov/grants/guide/pa-files/PAR-21-145.html

“NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 – Independent Clinical Trial Not Allowed),” (PAR-20-317, a reissue of PAR-17-290, National Institute on Aging, application deadlines May 25, 2021; May 25, 2022; May 25, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-20-317.html

“NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed),” (PAR-21-106, reissue of PAR-17-287, National Institute on Aging, application deadlines Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PAR-21-106.html

A. “Infectious Etiology of Alzheimer’s Disease (R01 Clinical Trial Optional),” (RFA-AG-21-034, National Institute on Aging, application deadline March 31, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-034.html

B. “BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed),” (RFA-EY-21-001, a reissue of RFA-EY-18-001, National Institute on Aging, in conjunction with other agencies, application deadlines May 3, 2021; October 29, 2021; May 2, 2022; October 28, 2022; May 1, 2023; October 27, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-EY-21-001.html

“Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional),” (PAR-21-100, National Institute on Aging, in conjunction with other agencies, application deadlines February 5, 2021, February 5, 2022, February 5, 2023). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional),” (PAR-21-099).

grants.nih.gov/grants/guide/pa-files/PAR-21-100.html

A. “2021 Empowering Communities to Reduce Falls and Falls Risk,” (HHS-2021-ACL-AOA-FPSG-0015, application deadline February 2, 2020).

www.grants.gov/web/grants/view-opportunity.html?oppId=329763

B. “2021 Integrated Networks to Deliver and Sustain Evidence-Based Falls Prevention Programs,” (HHS-2021-ACL-AOA-FPSG-0017, application deadline February 2, 2020).

www.grants.gov/web/grants/view-opportunity.html?oppId=329762

C. “2021 Integrated Networks to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs,” (HHS-2021-ACL-AOA-CSSG-0014, application deadline February 2, 2020).

www.grants.gov/web/grants/view-opportunity.html?oppId=329804

“Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed),” (RFA-AG-22-002, National Institute on Aging, application deadline June 15, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-002.html

“Interventional Cooperative Agreement Program Social Security Administration,” (ICAP-ICA-21-001, application deadline April 16, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=329609

“2021 Empowering Communities to Address Behavioral Health and Chronic Pain through Chronic Disease Self-Management Education Programs,” (HHS-2021-ACL-AOA-CSSG-0018, application deadline Feb. 2, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=329787

A. “Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required),” (PAR-20-309, a reissue of PAR-18-513, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-20-309.html

B. “Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional),” (PAR-21-068, a reissue of PAR-18-189, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional),” (PAR-21-069).

grants.nih.gov/grants/guide/pa-files/PAR-21-068.html

C. “Small Vessel VCID Biomarker Validation Consortium Sites (U01)(Clinical Trials Not Allowed),” (RFA-NS-21-005, a reissue of RFA-NS-16-020, National Institute on Aging, in conjunction with other agencies, application deadline March 9, 2021). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed),” (RFA-NS-21-004).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-005.html

A. “Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed),” (PAR-21-080, a reissue of PA-17-041, National Institute on Aging, in conjunction with other agencies, application deadlines Mar. 5, June 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional),” (PAR-21-081).

grants.nih.gov/grants/guide/pa-files/PAR-21-080.html

B. “Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed),” (PA-21-071, National Institute on Aging, in conjunction with other agencies, due dates by awarding IC).

grants.nih.gov/grants/guide/pa-files/PA-21-071.html

“Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed),” (PA-21-071, a reissue of PA-20-222, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-21-071.html

“Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed),” (PAR-20-038, National Institute on Aging, in conjunction with other agencies, January 26, 2021; May 26, 2021; September 28, 2021; January 26, 2022; May 26, 2022; September 27, 2022; January 26, 2023; May 26, 2023; September 26, 2023). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required),” (PAR-21-039).

grants.nih.gov/grants/guide/pa-files/PAR-21-038.html

“Disaster Assistance for State Units on Aging (SUAs) and Tribal Organizations in Major Disasters Declared by the President,” (HHS-2021-ACL-AOA-DASG-0002, application deadline September 7, 2021).

www.grants.gov/web/grants/view-opportunity.html?oppId=329319

“Treatments for Lewy Body Dementias–Exploratory Clinical Trial (U01 Clinical Trial Required),” (RFA-NS-21-008, National Institute on Aging, in conjunction with other agencies, application deadline March 2, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-008.html

A. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33),” (PA-21-047, a reissue of PA-20-247, National Institute on Aging, in conjunction with other agencies, application deadline Apr. 8, August 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-21-047.html

B. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31),” (PA-21-051, a reissue of PA-20-246, National Institute on Aging, in conjunction with other agencies, application deadline Apr. 8, August 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-21-051.html

C. “BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed),” (RFA-MH-21-140, a reissue of of RFA-MH-19-148, National Institute on Aging, in conjunction with other agencies, application deadline March 10, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-140.html

A. “Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed),” (PAR-21-028, a reissue of PAR-17-335, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 16, June 16, and Oct. 16).

grants.nih.gov/grants/guide/pa-files/PAR-21-028.html

B. “Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed),” (PAR-21-029, a reissue of PAR-17-336, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-21-029.html

“MD-PhD Training Program in Alzheimer’s Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed),” (RFA-AG-21-027, a reissue of of RFA-AG-20-032, National Institute on Aging, application deadline February 3, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-027.html

“BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32),” (RFA-MH-20-620, a reissue of RFA-MH-18-510, National Institute on Aging, in conjunction with other agencies, application deadlines December 9, 2020; August 10, 2021, April 11, 2022, December 9, 2022)

grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-620.

“Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed),” (PAR-20-258, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PAR-20-258.html

A. “Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required),” (RFA-AG-21-021, a reissue of RFA-AG-20-011, National Institute on Aging, application deadlines February 3, 2021, October 22, 2021, and October 21, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-021.html

B. “Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed),” (RFA-NS-21-007, National Institute on Aging, in conjunction with other agencies, application deadline October 27, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-007.html

A. “Mechanisms of Pathological Spread of Abnormal Proteins in LBD and FTD (R01 Clinical Trial Not Allowed),” (RFA-NS-21-006, National Institute on Aging, in conjunction with other agenices, application deadline October 27, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-006.html

B. “BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional),” (RFA-MH-20-600, a reissue of RFA-MH-19-145, National Institute on Aging, in conjunction with other agencies, application deadlines July 14, 2021, July 14, 2022, and July 14, 2023)

grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-600.html

C. “Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed),” (RFA-OD-20-014, National Institute on Aging, in conjunction with other agencies, application deadline Sept. 15, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-014.html

D. “Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed),” (RFA-OD-20-019, National Institute on Aging, in conjunction with other agenices, application deadline September 30, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-019.html

“Lifespan Respite Care Program: Special Projects to Strengthen Program Development, Implementation and Sustainability,” (HHS-2020-ACL-AOA-LRSP-0432, appliction deadline September 3, 2020).

www.grants.gov/web/grants/view-opportunity.html?oppId=328178

A. “Transition to Aging Research for Predoctoral Students (F99/K00),” (RFA-AG-21-022, National Institute on Aging, application deadline October 22, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-022.html

B. “Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional),” (RFA-AG-21-029, National Institute on Aging, application deadline November 10, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-029.html

“Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional),” (PAR-20-254, a reissue of PA-17-444, National Institute on Aging, in conjunction with other agencies, application deadline Sept. 5, Jan. 5, and Apr. 5). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional),” (PAR-20-257); and, “Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional),” (PAR-20-255).

grants.nih.gov/grants/guide/pa-files/PAR-20-254.html